» Articles » PMID: 35473752

HIF1α-SP1 Interaction Disrupts the Circ-0001875/miR-31-5p/SP1 Regulatory Loop Under a Hypoxic Microenvironment and Promotes Non-small Cell Lung Cancer Progression

Overview
Publisher Biomed Central
Specialty Oncology
Date 2022 Apr 27
PMID 35473752
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circular RNAs (circRNAs) play an important role in the progression of non-small cell lung cancer (NSCLC), especially under tumor hypoxia. However, the precise functions and underlying mechanisms of dysregulated circRNAs in NSCLC are largely unknown.

Methods: High-throughput RNA sequencing was performed to identify significantly expressed circRNAs in NSCLC tissues. The functions of circ-0001875 in NSCLC cells were investigated in vitro and in vivo. The regulatory relationships of circ-0001875, miR-31-5p and SP1 were examined by dual luciferase reporter assays and rescue experiments. The signal pathway of epithelial-to-mesenchymal transition and the formation of filopodia were analyzed by western blot and immunofluorescence staining. The binding of SP1 to Alu elements was evaluated by RNA immunoprecipitation, and the HIF1α and SP1 interaction was detected by co-immunoprecipitation.

Results: We identified the novel Has_circ_0001875 as a significantly upregulated circRNA in NSCLC tissues and cell lines. circ-0001875 promoted the proliferation and metastasis of NSCLC both in vitro and in vivo, and induced NSCLC cells to extend filopodia. Mechanistically, circ-0001875 sponged miR-31-5p to regulate SP1, influencing epithelial-to-mesenchymal transition via the TGFβ/Smad2 signal pathway. SP1 negatively regulated circ-0001875 formation through an AluSq-dependent feedback loop, which was disrupted by competitive binding of HIF1α to SP1 under hypoxia condition. The circ-0001875/miR-31-5p/SP1 axis was associated with the clinical features and prognosis of NSCLC patients.

Conclusions: Our results revealed that the circ-0001875/miR-31-5p/SP1 axis and the complex regulatory loops influence NSCLC progression. These findings provide new insights into the regulation of circRNA formation under tumor hypoxia.

Citing Articles

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment.

Gong L, Zou C, Zhang H, Yang F, Qi G, Ma Z Genes (Basel). 2025; 16(2).

PMID: 40004471 PMC: 11855738. DOI: 10.3390/genes16020140.


Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review.

Yang J, Luo Y, Yao Z, Wang Z, Jiang K Discov Oncol. 2025; 16(1):169.

PMID: 39937377 PMC: 11822152. DOI: 10.1007/s12672-025-01919-3.


Identification of genetic associations between acute myocardial infarction and non-small cell lung cancer.

Zheng H, Wang J, Zheng Y, Hong X, Wang L Front Mol Biosci. 2024; 11:1502509.

PMID: 39712244 PMC: 11659147. DOI: 10.3389/fmolb.2024.1502509.


In vitro production of viable eggs from undeveloped oocytes in mouse preantral follicles by reconstructing granulosa cell-oocyte complexes†.

Kohama T, Tomioka I, Morohaku K Biol Reprod. 2024; 111(5):1156-1167.

PMID: 39237319 PMC: 11565231. DOI: 10.1093/biolre/ioae125.


Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression.

Li L, Liu D, Chen T, Wei C, Qiao Y, Liu W J Exp Clin Cancer Res. 2024; 43(1):200.

PMID: 39030638 PMC: 11264895. DOI: 10.1186/s13046-024-03116-6.


References
1.
Zhang H, Wang E, Li L, Yi S, Li L, Xu F . A regulatory loop involving miR-29c and Sp1 elevates the TGF-β1 mediated epithelial-to-mesenchymal transition in lung cancer. Oncotarget. 2016; 7(52):85905-85916. PMC: 5349884. DOI: 10.18632/oncotarget.13137. View

2.
Osmani L, Askin F, Gabrielson E, Li Q . Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2017; 52(Pt 1):103-109. PMC: 5970946. DOI: 10.1016/j.semcancer.2017.11.019. View

3.
Pastushenko I, Blanpain C . EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2018; 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001. View

4.
Zhang X, Wang H, Zhang Y, Lu X, Chen L, Yang L . Complementary sequence-mediated exon circularization. Cell. 2014; 159(1):134-147. DOI: 10.1016/j.cell.2014.09.001. View

5.
Herbst R, Morgensztern D, Boshoff C . The biology and management of non-small cell lung cancer. Nature. 2018; 553(7689):446-454. DOI: 10.1038/nature25183. View